For this purpose, we utilized a CRISPR/Cas9-mediated gene editing approach to delete a portion of the ARID1A gene in four colorectal cancer cell lines (COLO320DM, DLD1, HCT116, and HT29). Here, ARID1A is linked to colorectal cancer.